Home  >  Feik School of Pharmacy  >  Academics  >  Residency Program  >  Research and Presentations

Research and Presentations

Research and dissemination of knowledge are important activities for all clinical pharmacists and educators. In this program, the resident is expected to gain experience with clinical or academic research with a research mentor and committee. Research activities may include writing an institutional review board proposal, writing a grant proposal, writing and submitting an original research manuscript as well as an additional peer-reviewed article, and responding to reviewer comments. In addition, dissemination of research and innovative ideas is a key function of clinical pharmacists and educators. Multiple presentations are required throughout the 24-month program to ensure that residents can artfully deliver both topic- and research-based formal presentations with appropriate depth and mastery of content.

Research  

Each resident is required to complete at least one major research project during the 24-month program. After the resident selects a topic or area of interest, the resident will select a research mentor. The resident and research mentor will invite appropriate faculty or preceptors to serve on the research committee. It is expected that the resident, by completion of the program, will have written and submitted at least one original research manuscript and one additional peer-reviewed article.

Each resident is required to present research findings at UIW Research Day in February of the second postgraduate year. In postgraduate year two, research results must also be presented in a formal research seminar at UIW  as well as UIW Research Day.  Residents are also required to present each year at ALCALDE Southwest Leadership Conference. A research timeline is available to guide residents with research deadlines and requirements.  Finally, residents will also present at least one poster or platform presentation at a professional meeting and participate in the peer-review process for one manuscript.

Continuing Education Presentation 

Each resident is also required to present one Accreditation Council for Pharmacy Education (ACPE) approved continuing education seminar through a professional organization. Local professional organizations to submit potential presentation requests to include, but are not limited to, the Bexar County Pharmacy Association (BCPA) and the Central Texas Society of Health-System Pharmacists (CTSHP).

Controversies in Clinical Therapeutics

Each resident will select a controversial topic in an area of interest to present in the Controversies in Clinical Therapeutics series. The purpose of the Controversies in Clinical Therapeutics series is to effectively and concisely provide evidence-based treatment recommendations on a controversial topic after an evaluation of appropriate evidence. Other goals of this presentation include development of verbal and written communication skills and clinical reasoning.

 

Examples of Research and Presentations

Presentations

Dr. Rebekah Benitez, PharmD: Too Much of a Good Thing? A Comparison of Standard versus Extended Dual Antiplatelet Therapy following the Placement of Drug-Eluting Stents. Presented at the University at the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. April 2017

Dr. Jenna Snoga, PharmD: Non-selective Beta-Blockers in Patients with Ascites: Friend or Foe? Presented at the University at the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. March 2017

Dr. Emily Brysch, PharmD: Should Dipeptidyl Peptidase-4 (DPP-4) Inhibitors be Avoided in Patients with Heart Failure? Presented at the University at the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. November 2016

Dr. Shelley Glaess, PharmD: Clonidine as a Strategy for Discontinuing Long-term Sedation with Dexmedetomidine in Critically Ill Patients. Presented at the University of the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. October 2016

Dr. Shelley Glaess, PharmD: Periprocedural Management of Anticoagulation in Atrial Fibrillation: When to Burn Your Bridges. Presented at the University of the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. March 2016

Dr. Emily Brysch, PharmD: Steroid Use in Community Acquired Pneumonia: Should the Idea be "Suppressed" or Standard of Care? Presented at the University of the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. January 2016

Dr. Alireza FakhriRavari, PharmD: β-lactam/β-lactamase inhibitors for the treatment of infections caused by ESBL-producing Enterobacteriaceae. Presented at the University of the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. November 2015

Dr. Ashley Zurek, PharmD: Pharmacologic Venous Thromboembolism Prophylaxis vs. Auto-anticoagulation in Cirrhosis.  Presented at the University of the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. October 2015

Dr. Alireza FakhriRavari, PharmD: “New and Emerging Interferon-free Treatments for Chronic Hepatitis C”. Presented at the TPA Conference & Expo for ACPE Continuing Education. July 2015

Dr. Hansita Patel, PharmD; “Cefepime use for ESBL infections”. Presented to the Central Texas Society of Health-System Pharmacists for ACPE Continuing Education. June 2015

Dr. Braden Adamson, PharmD: “Inhaled Anticholinergic Therapy and Cardiovascular Safety”; Presented to the Central Texas Society of Health-System Pharmacists for ACPE Continuing Education.  May 2015

Dr. Ashley Zurek, PharmD: “Are Sodium Glucose Cotransporter 2 Inhibitors Equally Effective in Hemoglobin A1c Lowering Potential?”. Presented to the Bexar County Pharmacy Association for ACPE Continuing Education. April 2015

Dr. Ashley Zurek, PharmD: “Sodium Glucose Cotransporter 2 Inhibitors – Are They Equal?”. Presented to the University of the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. March 2015

Dr. Alireza FakhriRavari, PharmD: “Interferon-free Treatments for Chronic Hepatitis C Genotype 1 Infection” Presented at the University of the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. January 2015

Dr. Hansita Patel, PharmD; “Cefepime use for ESBL infections: Usable or Inducible?” Presented at the University of the Incarnate Word Feik School of Pharmacy for ACPE Continuing Education. November 2014

Dr. Braden Adamson, PharmD: “Inhaled Anticholinergic Therapy and Cardiovascular Safety” presented as Controversies in Clinical Therapeutics to the FSOP faculty and San Antonio area pharmacists for ACPE Continuing Education. October 2014

Dr. Merlyn Joseph, PharmD: “Osteoporosis Prevention: A Focus on Calcium and Vitamin D”. Presented to the Bexar County Pharmacy Association for ACPE Continuing Education. May 2014

Dr. Tina Lee, PharmD: “Are Weight Loss Drugs and eCigarettes Seen on TV Safe and Effective?”. Presented to Bexar County Pharmacy Association for ACPE Continuing Education. February 2014

Dr. Tina Lee, PharmD: “Statin-Induced Rhabdomyolysis”. Presented to the Central Texas Society of Health-System Pharmacists for ACPE Continuing Education. January 2014

 

Poster Presentations

Glaess SS, Attridge RL, Brady RL, Attridge RT. Evaluation of Prophylactic Antibiotic Regimens on Recurrence and Mortality in Spontaneous Bacterial Peritonitis. Presented at American College of Clinical Pharmacy (ACCP) Annual Meeting, October 2016.

Brysch EG, Cauthon KAB, Sarbacker GB, Kalich BA. Reduction of Medication Regimen Complexity in Geriatric Patients: The Effect on Quality of Life and Functional Capacity. Presented at American College of Clinical Pharmacy (ACCP) Annual Meeting, October, 2016.

Glaess SS, Attridge RL, Brady RL, Attridge RT. Evaluation of Prophylactic Antibiotic Regimens on Recurrence and Mortality in Spontaneous Bacterial Peritonitis. Presented at TSHP Annual Seminar, April 2016.

Patel H, Attridge RL, Cauthon K, Horlen C, Urteaga, E, Witte A. Utilization of Twice Daily Dosing of Insulin Glargine in Type 2 Diabetes Mellitus. Presented at ACCP Global Conference on Clinical Pharmacy, October 2015.

Patel H, Espiritu B, Flynt M, Adamson B, Witte A, Sarbacker B. Identification and Reduction of Medication Complexity in Older Patients. Presented at UTHSCSA PASSPORT Research Forum, April 2015.

Patel H, Attridge RL, Cauthon K, Horlen C, Urteaga, E, Witte A. Utilization of Twice Daily Dosing of Insulin Glargine in Type 2 Diabetes Mellitus. Presented at ALCALDE Southwest Leadership Conference, April 2015.

Adamson B, Attridge RT. Community-Dwelling Pneumonia and Risk Factors for Resistant Pathogens. Presented at ALCALDE Southwest Leadership Conference in San Antonio, Texas, April 2015.

Lee TC, Attridge RT, Attridge RL, Horlen C, Cota J. Clinical Evaluation of Potassium Supplementation in Hospitalized Adults. Presented at ALCALDE Southwest Leadership Conference, April 2014.

Joseph M, Attridge RT, Brady R, Cota J, Horlen C, Lusk K, Attridge RL. Factors associated with fluconazole-induced hepatotoxicity. Presented at ALCALDE Southwest Leadership Conference, April 2014.

Joseph M, Lee TC, Sarbacker B, Horlen C. Impact of Geriatric Education on Second Year Pharmacy Students. Presented at the Chief Resident Immersion Training Poster Presentations, University of Texas Health Sciences Center, April 2014.

Lee TC, Joseph M, Sarbacker B, Horlen C. Impact of Geriatric Education on Second Year Pharmacy Students. Presented at the 7th Annual University of the Incarnate Word Research Day, February 2014.

 

Publications 

Lusk KA, Snoga JL, Benitez RM, Sarbacker GB. Management of direct-acting oral anticoagulants surrounding dental procedures with low-to-moderate risk of bleeding. J Pharm Pract 2017;897. Available at: https://www.ncbi.nlm.nih.gov/pubmed/28506106.

Zurek A, Urteaga E, Yendapally R. A review of the efficacy and safety of SGLT2 inhibitors: a focus on diabetic ketoacidosis. Diabetes Spectrum 2017. Available at: http://spectrum.diabetesjournals.org/content/30/2/137

Bazaldua OV, Davidson DA, Zurek A, Kripalani S. Chapter e1: Health literacy and medication use. In: Dipiro JT, Talbert RL, Yee GC, Matzke CR, Wells BG, Posey L. eds. Pharmacotherapy: A Pathophysiologic Approach, 10e. New York, NY: McGraw-Hill;2017. Available at: www.accesspharmacy.com

Sanchez CK, Zurek A. Patient perceptions of generic drugs: dispelling misconceptions. US Pharmacist 2016;41(Generic Drugs suppl):36-41. Available at: https://www.uspharmacist.com/article/patient-perceptions-of-generic-drugs-dispelling-misconceptions

Cota JM, FakhriRavari A, Rowan MP, Chung KK, Murray CK, Akers KS. Intravenous antibiotic and antifungal agent pharmacokinetic-pharmacodynamic dosing in adults with severe burn injury. Clin Ther 2016;epub ahead of print August 29, 2016. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27586127

FakhriRavari A, Malakouti M, Brady R. Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection.  J Clin Transl Hepatol. 2016 Jun 28;4(2):97-112. doi: 10.14218/JCTH.2016.00007. Epub 2016 Jun 15. Available at: https://www.ncbi.nlm.nih.gov/pubmed/?term=27350940

Joseph M, Lopez TC. Question On Evidence: Should Women Be On Statins For Secondary Prevention? (update). In: Linn WD, Al-Qadheeb N, Havrda D, Al-Qadheeb N, Havrda D, eds. Topics in Evidence-Based Pharmacy Practice. New York: McGraw-Hill; 2012. Available at: http://www.accesspharmacy.com/content.aspx?aID=4000225

Lee TC, Lopez TC. Is Increasing the Dose of Clopidogrel Effective in Clopidogrel Resistant Patients in Preventing Cardiovascular and Cerebrovascular Events Post PCI? (update). In W.D. Linn, N. Al-Qadheeb, D. Havrda, N. Al-Qadheeb, D. Havrda (Eds), Topics in Evidence-Based Pharmacy Practice; 2012. Available at: http://www.accesspharmacy.com/content.aspx?aID=4000227